[View Original Text]
On 27th of February, AIDOT, an artificial intelligence (AI) medical company announced that they introduced Cerviray, an AI system for remote diagnosis of cervical cancer screening
targeting health authorities and medical staff in Bolivia in South America, and they discussed plans to introduce screening through the KOICA Innovative Technology Program (CTS)
project.
The company explained that it grasped the current status of cervical cancer screening service in Bolivia through meetings with the Bolivian Ministry of Health, El Alto Korea Hospital,
and local women's hospitals, and informed the need for a screening program through the introduction and demonstration of Cerviray's products.
An official of AIDOT said, "We plan to complete Bolivia's AGEMED certification within the first half of this year, and all meetings with local medical device conglomerates have been
completed positively. Therefore we could expect successful commercialization in the first half of the year."
He also said, "Cerviray based on VIA test, which is possible without special medical infrastructure, is expected to make a great contribution to preventing cervical cancer as it can
quickly and easily perform cervical cancer screening in Bolivia's poor medical environment" .
Through this KOICA's CTS program, AIDOT plans to provide equipment
which converted to global end-user sales worth 1 million dollars, and conduct a free screening program in Bolivia
Korea Economy TV / Reporter Jae-joon Yang / 27th. Feb. 2023
Comments can be added by Member only